Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increasing levodopa for musculoskeletal pain in Parkinson's disease
RBR-103bk9wnPhase 4Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levodopa + benserazide and Placebo-COD Research Private Ltd in Parkinson's disease (PD) and chronic musculoskeletal pain (4 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Aug 2025; status: recruiting.
02
Drugs
levodopa + benserazidePlacebo-COD Research Private Ltd
03
Conditions
Parkinson's disease (PD)chronic musculoskeletal pain
Beyond the preview
Go deeper on RBR-103bk9wn.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-103bk9wn.